Claims for Patent: 9,220,694
✉ Email this page to a colleague
Summary for Patent: 9,220,694
Title: | Emulsion compositions containing cetalkonium chloride |
Abstract: | Compositions containing quaternary compounds in which the nitrogen atom is substituted by at least one alkyl group having at least 12 carbon atoms, and the composition includes at least 20% in weight by weight of the total composition, of ammonium halides in which the nitrogen atom is substituted by at least one alkyl group having at least 14 carbon atoms and more than 5%, preferably more than 7% in weight by weight of the total composition, of ammonium halides in which the nitrogen atom is substituted by at least one alkyl group having at least 16 carbon atoms. Also, ophthalmic oil-in-water emulsions containing such compositions, the ophthalmic emulsions being useful for eye care or for the treatment of eye conditions. |
Inventor(s): | Rabinovich-Guilatt; Laura (Kadima, IL), Lambert; Gregory (Chatenay Malabry, FR), Lallemand; Frederic (Fresnes, FR), Philips; Betty (Antony, FR) |
Assignee: | SANTEN SAS (Evry, FR) |
Application Number: | 13/957,621 |
Patent Claims: |
1. An oil-in-water emulsion comprising: an oil phase comprising mineral oil, castor oil or medium chain triglycerides; 0.0005% to 0.1% w/w of ammonium halide,
cetalkonium chloride being the sole ammonium halide of the emulsion; and 0.1% to 1% w/w of surfactant selected from tyloxapol, poloxamer 188, or a mixture thereof.
2. The oil-in-water emulsion according to claim 1, wherein the mineral oil is a mixture of heavy and light mineral oil. 3. The oil-in-water emulsion according to claim 1, further comprising buffering agents and/or at least one tonicity agent. 4. The oil-in-water emulsion according to claim 3, wherein the tonicity agent is mannitol. 5. The oil-in-water emulsion according to claim 3, wherein the tonicity agent is glycerol. 6. The oil-in-water emulsion according to claim 1, said emulsion having a positive zeta potential. 7. The oil-in-water emulsion according to claim 1, said emulsion having a droplet size of 100 to 500 nm. 8. The oil-in-water emulsion according to claim 1, said emulsion comprising light and heavy mineral oil, tyloxapol, poloxamer 188, mannitol and cetalkonium chloride. 9. The oil-in-water emulsion according to claim 1, said emulsion comprising light and heavy mineral oil, tyloxapol, poloxamer 188, glycerol and cetalkonium chloride. 10. The oil-in-water emulsion according to claim 1, said emulsion being hypotonic, relative to normal tears. 11. The oil-in-water emulsion according to claim 1, wherein said emulsion is in the form of a gel suitable for ophthalmic use. 12. The oil-in-water emulsion according to claim 1, being less toxic than a solution comprising the same amount of cetalkonium chloride, in weight by weight of the solution. 13. The oil-in-water emulsion according to claim 1, further comprising an active principle. 14. The oil-in-water emulsion according to claim 13, wherein the active principle is cyclosporine. 15. A medicament comprising the oil-in-water emulsion according to claim 1. 16. A method for preparing an ophthalmic composition for dry eye treatment, comprising preparing the emulsion according to claim 1 in a gel form. 17. A kit for dry eye treatment comprising a first emulsion according to claim 1 and a second emulsion containing cyclosporine. 18. The medicament according to claim 15, wherein said emulsion is in a gel form suitable for ophthalmic use. |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.